Annual EBITDA:
$49.90M+$23.80M(+91.20%)Summary
- As of today, TGTX annual EBITDA is $49.90 million, with the most recent change of +$23.80 million (+91.20%) on December 31, 2024.
- During the last 3 years, TGTX annual EBITDA has risen by +$391.87 million (+114.59%).
- TGTX annual EBITDA is now at all-time high.
Performance
TGTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$37.64M+$25.36M(+206.46%)Summary
- As of today, TGTX quarterly EBITDA is $37.64 million, with the most recent change of +$25.36 million (+206.46%) on June 30, 2025.
- Over the past year, TGTX quarterly EBITDA has increased by +$27.04 million (+255.06%).
- TGTX quarterly EBITDA is now -68.04% below its all-time high of $117.77 million, reached on September 30, 2023.
Performance
TGTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$97.66M+$27.04M(+38.28%)Summary
- As of today, TGTX TTM EBITDA is $97.66 million, with the most recent change of +$27.04 million (+38.28%) on June 30, 2025.
- Over the past year, TGTX TTM EBITDA has dropped by -$10.90 million (-10.04%).
- TGTX TTM EBITDA is now -10.04% below its all-time high of $108.56 million, reached on June 30, 2024.
Performance
TGTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TGTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +91.2% | +255.1% | -10.0% |
| 3Y3 Years | +114.6% | +200.7% | +134.9% |
| 5Y5 Years | +129.8% | +174.4% | +143.7% |
TGTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +114.6% | -68.0% | +149.9% | -10.0% | +142.5% |
| 5Y | 5-Year | at high | +114.6% | -68.0% | +140.8% | -10.0% | +128.6% |
| All-Time | All-Time | at high | +114.6% | -68.0% | +140.8% | -10.0% | +128.6% |
TGTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $37.64M(+206.5%) | $97.66M(+38.3%) |
| Mar 2025 | - | $12.28M(-62.3%) | $70.62M(+41.2%) |
| Dec 2024 | $49.90M(+91.2%) | $32.58M(+114.8%) | $50.03M(+740.6%) |
| Sep 2024 | - | $15.16M(+43.1%) | $5.95M(-94.5%) |
| Jun 2024 | - | $10.60M(+227.6%) | $108.56M(+100.8%) |
| Mar 2024 | - | -$8.31M(+27.8%) | $54.06M(+107.1%) |
| Dec 2023 | $26.10M(+112.2%) | -$11.50M(-109.8%) | $26.10M(+168.9%) |
| Sep 2023 | - | $117.77M(+368.3%) | -$37.88M(+80.0%) |
| Jun 2023 | - | -$43.90M(-21.0%) | -$189.69M(-3.6%) |
| Mar 2023 | - | -$36.27M(+52.0%) | -$183.15M(+14.1%) |
| Dec 2022 | -$213.11M(+37.7%) | -$75.48M(-121.7%) | -$213.11M(+7.2%) |
| Sep 2022 | - | -$34.04M(+8.9%) | -$229.75M(+18.0%) |
| Jun 2022 | - | -$37.36M(+43.6%) | -$280.18M(+12.3%) |
| Mar 2022 | - | -$66.22M(+28.1%) | -$319.57M(+6.5%) |
| Dec 2021 | -$341.97M(-25.4%) | -$92.13M(-9.1%) | -$341.97M(-1.6%) |
| Sep 2021 | - | -$84.47M(-10.1%) | -$336.66M(+0.3%) |
| Jun 2021 | - | -$76.75M(+13.4%) | -$337.65M(-8.4%) |
| Mar 2021 | - | -$88.62M(-2.1%) | -$311.46M(-14.2%) |
| Dec 2020 | -$272.68M(-63.0%) | -$86.82M(-1.6%) | -$272.68M(-22.0%) |
| Sep 2020 | - | -$85.46M(-69.0%) | -$223.46M(-12.7%) |
| Jun 2020 | - | -$50.57M(-1.5%) | -$198.32M(-8.5%) |
| Mar 2020 | - | -$49.83M(-32.5%) | -$182.82M(-9.3%) |
| Dec 2019 | -$167.30M(+2.9%) | -$37.60M(+37.7%) | -$167.30M(+8.7%) |
| Sep 2019 | - | -$60.32M(-72.0%) | -$183.28M(-17.1%) |
| Jun 2019 | - | -$35.07M(-2.2%) | -$156.57M(+5.3%) |
| Mar 2019 | - | -$34.31M(+36.0%) | -$165.40M(+4.2%) |
| Dec 2018 | -$172.38M(-46.8%) | -$53.58M(-59.4%) | -$172.64M(-16.0%) |
| Sep 2018 | - | -$33.61M(+23.4%) | -$148.87M(-1.4%) |
| Jun 2018 | - | -$43.90M(-5.6%) | -$146.83M(-11.8%) |
| Mar 2018 | - | -$41.56M(-39.4%) | -$131.33M(-11.8%) |
| Dec 2017 | -$117.42M(-48.8%) | -$29.81M(+5.6%) | -$117.42M(-5.2%) |
| Sep 2017 | - | -$31.56M(-11.1%) | -$111.62M(-6.3%) |
| Jun 2017 | - | -$28.40M(-2.7%) | -$104.96M(-13.4%) |
| Mar 2017 | - | -$27.65M(-15.2%) | -$92.57M(-17.3%) |
| Dec 2016 | -$78.91M(-24.9%) | -$24.01M(+3.6%) | -$78.91M(-7.4%) |
| Sep 2016 | - | -$24.91M(-55.6%) | -$73.47M(-18.6%) |
| Jun 2016 | - | -$16.01M(-14.4%) | -$61.97M(+1.3%) |
| Mar 2016 | - | -$13.99M(+24.7%) | -$62.81M(+0.6%) |
| Dec 2015 | -$63.16M(-13.4%) | -$18.57M(-38.5%) | -$63.16M(+1.3%) |
| Sep 2015 | - | -$13.40M(+20.5%) | -$64.03M(+5.6%) |
| Jun 2015 | - | -$16.85M(-17.5%) | -$67.84M(-8.1%) |
| Mar 2015 | - | -$14.34M(+26.2%) | -$62.73M(-12.6%) |
| Dec 2014 | -$55.72M(-185.4%) | -$19.43M(-12.9%) | -$55.72M(-33.6%) |
| Sep 2014 | - | -$17.22M(-46.5%) | -$41.71M(-44.8%) |
| Jun 2014 | - | -$11.75M(-60.5%) | -$28.81M(-23.1%) |
| Mar 2014 | - | -$7.32M(-35.0%) | -$23.40M(-19.9%) |
| Dec 2013 | -$19.52M(+21.7%) | -$5.42M(-25.7%) | -$19.52M(-14.5%) |
| Sep 2013 | - | -$4.32M(+32.0%) | -$17.04M(-12.1%) |
| Jun 2013 | - | -$6.34M(-84.3%) | -$15.21M(-35.7%) |
| Mar 2013 | - | -$3.44M(-17.0%) | -$11.21M(+55.1%) |
| Dec 2012 | -$24.95M(-2728.5%) | -$2.94M(-18.6%) | -$24.95M(-10.6%) |
| Sep 2012 | - | -$2.48M(-5.8%) | -$22.56M(-12.2%) |
| Jun 2012 | - | -$2.35M(+86.3%) | -$20.11M(-11.3%) |
| Mar 2012 | - | -$17.18M(-2995.4%) | -$18.06M(+5.7%) |
| Dec 2011 | -$882.00K(+56.2%) | -$554.90K(-1743.5%) | -$19.15M(+12.2%) |
| Sep 2011 | - | -$30.10K(+89.9%) | -$21.81M(-2.0%) |
| Jun 2011 | - | -$297.00K(+98.4%) | -$21.39M(+1.0%) |
| Mar 2011 | - | -$18.27M(-468.7%) | -$21.61M(-458.0%) |
| Dec 2010 | -$2.01M | -$3.21M(-921.2%) | -$3.87M(-286.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $391.10K(+174.7%) | -$1.00M(+44.0%) |
| Jun 2010 | - | -$523.50K(+1.0%) | -$1.79M(-2.7%) |
| Mar 2010 | - | -$528.60K(-55.4%) | -$1.74M(+1.5%) |
| Dec 2009 | -$1.77M(+59.7%) | -$340.10K(+13.8%) | -$1.77M(-28.8%) |
| Sep 2009 | - | -$394.40K(+17.1%) | -$1.37M(+41.7%) |
| Jun 2009 | - | -$475.80K(+14.4%) | -$2.35M(+29.5%) |
| Mar 2009 | - | -$555.80K(-1108.7%) | -$3.34M(+23.9%) |
| Dec 2008 | -$4.39M(+63.7%) | $55.10K(+104.0%) | -$4.39M(+30.9%) |
| Sep 2008 | - | -$1.38M(+5.7%) | -$6.35M(+17.2%) |
| Jun 2008 | - | -$1.46M(+9.1%) | -$7.67M(+31.0%) |
| Mar 2008 | - | -$1.61M(+15.9%) | -$11.12M(+8.0%) |
| Dec 2007 | -$12.10M(-21.7%) | -$1.91M(+29.1%) | -$12.10M(+9.4%) |
| Sep 2007 | - | -$2.70M(+45.1%) | -$13.35M(-5.9%) |
| Jun 2007 | - | -$4.91M(-90.4%) | -$12.60M(-25.6%) |
| Mar 2007 | - | -$2.58M(+18.5%) | -$10.04M(-1.0%) |
| Dec 2006 | -$9.94M(+48.5%) | -$3.16M(-62.3%) | -$9.94M(+53.3%) |
| Sep 2006 | - | -$1.95M(+16.7%) | -$21.29M(-0.4%) |
| Jun 2006 | - | -$2.34M(+5.6%) | -$21.20M(-4.2%) |
| Mar 2006 | - | -$2.48M(+82.9%) | -$20.35M(-5.5%) |
| Dec 2005 | -$19.30M(-220.9%) | -$14.51M(-679.7%) | -$19.29M(-195.7%) |
| Sep 2005 | - | -$1.86M(-25.1%) | -$6.52M(+5.0%) |
| Jun 2005 | - | -$1.49M(-4.4%) | -$6.87M(-8.5%) |
| Mar 2005 | - | -$1.42M(+18.6%) | -$6.33M(-5.2%) |
| Dec 2004 | -$6.01M(-31.6%) | -$1.75M(+20.6%) | -$6.01M(-4.0%) |
| Sep 2004 | - | -$2.20M(-131.5%) | -$5.78M(-3.8%) |
| Jun 2004 | - | -$951.60K(+14.3%) | -$5.57M(-5.1%) |
| Mar 2004 | - | -$1.11M(+26.9%) | -$5.30M(-16.0%) |
| Dec 2003 | -$4.57M(-359.0%) | -$1.52M(+23.7%) | -$4.57M(-58.5%) |
| Sep 2003 | - | -$1.99M(-192.3%) | -$2.88M(-94.6%) |
| Jun 2003 | - | -$680.80K(-79.1%) | -$1.48M(-41.2%) |
| Mar 2003 | - | -$380.20K(-325.9%) | -$1.05M(+18.5%) |
| Dec 2002 | -$995.50K(+67.3%) | $168.30K(+128.6%) | -$1.29M(+35.7%) |
| Sep 2002 | - | -$588.20K(-136.4%) | -$2.00M(+5.0%) |
| Jun 2002 | - | -$248.80K(+59.8%) | -$2.11M(+36.4%) |
| Mar 2002 | - | -$618.40K(-13.1%) | -$3.32M(-14.5%) |
| Dec 2001 | -$3.04M(+1.5%) | -$547.00K(+21.1%) | -$2.89M(>-9900.0%) |
| Sep 2001 | - | -$693.40K(+52.4%) | -$5400.00(+97.9%) |
| Jun 2001 | - | -$1.46M(-637.8%) | -$256.70K(+86.4%) |
| Mar 2001 | - | -$197.40K(-108.4%) | -$1.88M(+38.7%) |
| Dec 2000 | -$3.09M(-18.7%) | $2.34M(+347.9%) | -$3.07M(+48.9%) |
| Sep 2000 | - | -$944.70K(+69.3%) | -$6.01M(-8.0%) |
| Jun 2000 | - | -$3.08M(-122.1%) | -$5.57M(-74.7%) |
| Mar 2000 | - | -$1.39M(-131.2%) | -$3.19M(-13.8%) |
| Dec 1999 | -$2.60M(+13.3%) | -$600.00K(-20.0%) | -$2.80M(+20.0%) |
| Sep 1999 | - | -$500.00K(+28.6%) | -$3.50M(+16.7%) |
| Jun 1999 | - | -$700.00K(+30.0%) | -$4.20M(-55.6%) |
| Mar 1999 | - | -$1.00M(+23.1%) | -$2.70M(+10.0%) |
| Dec 1998 | -$3.00M(+42.3%) | -$1.30M(-8.3%) | -$3.00M(+9.1%) |
| Sep 1998 | - | -$1.20M(-250.0%) | -$3.30M(-6.5%) |
| Jun 1998 | - | $800.00K(+161.5%) | -$3.10M(+44.6%) |
| Mar 1998 | - | -$1.30M(+18.8%) | -$5.60M(-9.8%) |
| Dec 1997 | -$5.20M(-40.5%) | -$1.60M(-60.0%) | -$5.10M(-10.9%) |
| Sep 1997 | - | -$1.00M(+41.2%) | -$4.60M(+2.1%) |
| Jun 1997 | - | -$1.70M(-112.5%) | -$4.70M(-30.6%) |
| Mar 1997 | - | -$800.00K(+27.3%) | -$3.60M(-33.3%) |
| Dec 1996 | -$3.70M | -$1.10M(0.0%) | -$2.70M(-68.8%) |
| Sep 1996 | - | -$1.10M(-83.3%) | -$1.60M(-220.0%) |
| Jun 1996 | - | -$600.00K(-700.0%) | -$500.00K(-600.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is TG Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual EBITDA year-on-year change?
- What is TG Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is TG Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. TTM EBITDA year-on-year change?
What is TG Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of TGTX is $49.90M
What is the all-time high annual EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual EBITDA is $49.90M
What is TG Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, TGTX annual EBITDA has changed by +$23.80M (+91.20%)
What is TG Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of TGTX is $37.64M
What is the all-time high quarterly EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly EBITDA is $117.77M
What is TG Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, TGTX quarterly EBITDA has changed by +$27.04M (+255.06%)
What is TG Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of TGTX is $97.66M
What is the all-time high TTM EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high TTM EBITDA is $108.56M
What is TG Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, TGTX TTM EBITDA has changed by -$10.90M (-10.04%)